Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS‐K)
Authors:
- 16 July 2002
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (9) , 797-803
Abstract
Objective: The purpose of this study was the development of the Korean Version of Alzheimer's Disease Assessment Scale (ADAS‐K).Method: ADAS‐K was administrated to 84 AD patients as well as 105 non‐demented control subjects. Three aspects of reliability were tested. To evaluate the validity of ADAS‐K, discriminant validity and concurrent validity were tested. To evaluate the sensitivity of ADAS‐K to disease severity, all subjects, AD patients and control subjects, were grouped by CDR scale and their mean scores on ADAS‐K were compared.Result: ADAS‐K demonstrated high levels of reliability. Mean ADAS‐K scores for AD patients were significantly different from the control group (p < 0.01). Furthermore, ADAS‐K exhibited significant correlations with other tests and scales (range 0.45–0.85, p < 0.01). In ROC curve analysis, ADAS‐K displayed high diagnostic efficacy and the optimal cut‐off point was selected between 18/19. ADAS‐K was able to discriminate the degree of AD severity according to CDR classification. Our results suggested that ADAS‐K‐cog was sensitive to very mild AD.Conclusion: We demonstrated that ADAS‐K is a reliable and valid instrument not only for AD diagnosis but also for evaluation of its severity. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Validity of Different Linguistic Versions of the Alzheimer’s Disease Assessment Scale in an International Multicentre Alzheimer’s Disease TrialDementia and Geriatric Cognitive Disorders, 1999
- Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsawBMJ, 1999
- Alzheimer's Disease Assessment Scale: The Validation of the Scale in Greece in Elderly Demented Patients and Normal SubjectsDementia and Geriatric Cognitive Disorders, 1997
- Development of Cognitive Instruments for Use in Clinical Trials of Antidementia DrugsAlzheimer Disease & Associated Disorders, 1997
- The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled TrialDementia and Geriatric Cognitive Disorders, 1996
- Comprehensive and Neuropsychologic EvaluationsInternational Psychogeriatrics, 1996
- Alzheimer Disease Assessment ScaleAlzheimer Disease & Associated Disorders, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978